Matthew Rabinowitz, the Executive Chairman of Natera, Inc., has donated 6,000 shares of common stock in a charitable contribution. This action, reported in a recent SEC filing, highlights his commitment to philanthropy while maintaining a substantial ownership stake in the company.
This donation was reported in a Form 4 filing dated October 9, 2026, with the transaction taking place on October 7, 2026. Following this contribution, Rabinowitz still holds over 2.1 million shares of Natera, reflecting his ongoing investment in the company’s future.
Background
Natera, Inc. is a company based in Austin, Texas, that specializes in medical laboratory services. It operates under the Central Index Key (CIK) 0001604821. The company is known for its innovative approaches in genetic testing and diagnostics, contributing to advancements in personalized medicine.
What the Filing Says
The filing indicates that the 6,000 shares were disposed of as part of a charitable contribution. A footnote in the filing states, "Represents a charitable contribution by the Reporting Person." This reflects Rabinowitz's philanthropic efforts while still retaining a significant stake in Natera.
Impact
This charitable act may resonate with shareholders and the broader community, potentially enhancing the company's image as one that values social responsibility. Rabinowitz's continued ownership of over 2.1 million shares may also reassure investors about his commitment to Natera's long-term success.
What's Next
The filing does not say what happens next.